BioCentury

Microbiotal reverse-engineering: How Finch is moving from fecal microbiota transplant to oral therapy

Microbiotal reverse-engineering: How Finch is moving from fecal microbiota transplant to oral therapy

Finch Therapeutics Inc. is developing an oral alternative to fecal microbial transplant that it believes entails less biology risk than more advanced oral candidates, with more targeted delivery than full microbiome transplants delivered via enema.